e-therapeutics (LON:ETX) Shares Pass Below 200 Day Moving Average of $11.85

e-therapeutics plc (LON:ETX)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 11.85 ($0.15) and traded as low as GBX 8.54 ($0.11). e-therapeutics shares last traded at GBX 9.60 ($0.12), with a volume of 2,228,014 shares trading hands.

e-therapeutics Stock Performance

The stock’s 50 day moving average price is GBX 12.13 and its 200 day moving average price is GBX 11.82. The company has a debt-to-equity ratio of 0.33, a quick ratio of 20.13 and a current ratio of 22.20. The company has a market capitalization of £57.26 million, a P/E ratio of -490.00 and a beta of 0.48.

About e-therapeutics

e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.